Cargando…

Bystander preference for naloxone products: a field experiment

BACKGROUND: Bystander administration of naloxone is a critical strategy to mitigate opioid overdose mortality. To ensure bystanders’ willingness to carry and administer naloxone in response to a suspected overdose, it is critical to select products for community distribution with the highest likelih...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marks, Katherine R., Oyler, Douglas R., Strickland, Justin C., Jaggers, Jody, Roberts, Monica F., Miracle, Dustin K., Barnes, Chase, Lei, Feitong, Smith, Amanda, Mackin, Eric, Martin, Martika C., Freeman, Patricia R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685501/ https://www.ncbi.nlm.nih.gov/pubmed/38017424 http://dx.doi.org/10.1186/s12954-023-00904-9

Ejemplares similares

Untrained Bystanders Administering Drone-Delivered Naloxone: An Exploratory Study
por: Adams, Nicole, et al.
Publicado: (2023)

Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a “hub with many spokes” model
por: Knudsen, Hannah K., et al.
Publicado: (2023)

Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States
por: Sohn, Minji, et al.
Publicado: (2019)

Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis
por: Giglio, Rebecca E, et al.
Publicado: (2015)

Low-energy Bluetooth for detecting real-world penetrance of bystander naloxone kits: a pilot study
por: Lai, Jeffrey T., et al.
Publicado: (2018)

Real-world study of multiple naloxone administration for opioid overdose reversal among bystanders
por: Abdelal, Randa, et al.
Publicado: (2022)

Drugs involved in Kentucky drug poisoning deaths and relation with antecedent controlled substance prescription dispensing
por: Freeman, Patricia R., et al.
Publicado: (2023)

Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study
por: Moustaqim-Barrette, Amina, et al.
Publicado: (2021)

Naloxone Audit
por: Venan, Paster
Publicado: (2023)

Point-of-sale Naloxone: Novel Community-based Research to Identify Naloxone Availability
por: Olives, Travis, et al.
Publicado: (2020)

Biphasic Effects of Naloxone in the Rats Receiving Morphine Overdose A Place Preference Study
por: Karimi, Sara, et al.
Publicado: (2011)

Assessment of naloxone as a therapeutic for inhaled carfentanil in the ferret
por: McCranor, Bryan J., et al.
Publicado: (2020)

Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy
por: Dachs, Gabi U., et al.
Publicado: (2009)

Medicaid prescription limits and their implications for naloxone accessibility
por: Roberts, Andrew W., et al.
Publicado: (2021)

Naloxone distribution and possession following a large‐scale naloxone programme
por: Madah‐Amiri, Desiree, et al.
Publicado: (2018)

The status of naloxone in community pharmacies across Canada
por: So, Randy, et al.
Publicado: (2020)

A Study on the Efficacy of a Naloxone Training Program
por: Beauchamp, Gillian A, et al.
Publicado: (2021)

The policy landscape for naloxone distribution in four states highly impacted by fatal opioid overdoses
por: Bohler, Robert M., et al.
Publicado: (2022)

Bystander
por: Gorky, Maksim, 1868-1936
Publicado: (1930)

Closed-loop wearable naloxone injector system
por: Chan, Justin, et al.
Publicado: (2021)

Clathrin: Bender or bystander?
por: Stachowiak, Jeanne C.
Publicado: (2022)

The bystander effect in rats
por: Havlik, John L., et al.
Publicado: (2020)

Canadian national consensus guidelines for naloxone prescribing by pharmacists
por: Tsuyuki, Ross T., et al.
Publicado: (2020)

Bystanders or not? Microglia and lymphocytes in aging and stroke
por: Nguyen, Justin N., et al.
Publicado: (2022)

Involvement of energy metabolism in the production of ‘bystander effects’ by radiation
por: Mothersill, C, et al.
Publicado: (2000)

Letter to the Editor regarding: Medicaid prescription limits and their implications for naloxone accessibility (by Roberts et al., 2021)
por: Talbert, Jeffery, et al.
Publicado: (2021)

Use of naloxone in valproate overdose
por: Sanaei-Zadeh, Hossein
Publicado: (2012)

Effects of naloxone on phagocyte functions
por: Delvaux, B, et al.
Publicado: (2006)

Naloxone induced pulmonary edema
por: Elkattawy, Sherif, et al.
Publicado: (2021)

Bystander CPR
por: Eisenberg, Mickey
Publicado: (1994)

The Bystander Effect of Ultraviolet Radiation and Mediators
por: Z., Eftekhari, et al.
Publicado: (2020)

MRC5 and QU-DB bystander cells can produce bystander factors and induce radiation bystander effect
por: Toossi, Mohammad Taghi Bahreyni, et al.
Publicado: (2014)

Preventing opioid overdose with peer-administered naloxone: findings from a rural state
por: Hanson, Bridget L., et al.
Publicado: (2020)

Will converting naloxone to over‐the‐counter status increase pharmacy sales?
por: Murphy, Sean M., et al.
Publicado: (2019)

Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates
por: Gangal, Neha S., et al.
Publicado: (2020)

The Mechanisms of Radiation-Induced Bystander Effect
por: Najafi, M, et al.
Publicado: (2014)

Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study
por: Bennett, Alex S, et al.
Publicado: (2020)

Overdose education and naloxone distribution program design informed by people who use drugs and naloxone distributors
por: Enich, Michael, et al.
Publicado: (2023)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Observing others give & take: A computational account of bystanders’ feelings and actions
por: Blain, Bastien, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_84repnnbhbrbsvtgg6ehpiqe66